Posted On: 12/29/2014 11:10:10 AM
Post# of 30066
Four things will be distinguishing Gerald's LymPro report this Conference from past Conferences and updates:
1) This will contain the fullest set of data,
2) LymPro is NOW READY for use by researchers,
3) LymPro may by then have actual SALES under it's belt.
4) He will be announcing plans for it's Spin Off.
Institutional investors will be highly interested in this.
1) This will contain the fullest set of data,
2) LymPro is NOW READY for use by researchers,
3) LymPro may by then have actual SALES under it's belt.
4) He will be announcing plans for it's Spin Off.
Institutional investors will be highly interested in this.
(0)
(0)
